- Home
- XENE vs RLI Comparison
XENE vs RLI Comparison
Compare XENE & RLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XENE | RLI |
|---|---|---|
| Founded | 1996 | 1965 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.5B |
| IPO Year | 2014 | 1994 |
Fundamental Metrics
Financial Performance| Metric | XENE | RLI |
|---|---|---|
| Price | $62.35 | $63.77 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 7 |
| Target Price | ★ $68.55 | $62.40 |
| AVG Volume (30 Days) | 654.5K | ★ 867.0K |
| Earning Date | 05-08-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 5.16% |
| EPS Growth | N/A | ★ 16.84 |
| EPS | N/A | ★ 2.42 |
| Revenue | $311,000.00 | ★ $1,882,448,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,496.48 | $3.53 |
| P/E Ratio | ★ N/A | $26.44 |
| Revenue Growth | N/A | ★ 6.33 |
| 52 Week Low | $35.60 | $47.26 |
| 52 Week High | $72.66 | $69.19 |
Technical Indicators
Market Signals| Indicator | XENE | RLI |
|---|---|---|
| Relative Strength Index (RSI) | 45.39 | 57.38 |
| Support Level | $61.16 | $60.23 |
| Resistance Level | $62.91 | $64.08 |
| Average True Range (ATR) | 2.15 | 1.79 |
| MACD | -0.39 | -0.14 |
| Stochastic Oscillator | 19.72 | 55.11 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About RLI RLI Corp. (DE)
RLI Corp underwrites property and casualty insurance through its subsidiaries. The company offers insurance coverage in the specialty admitted market, where the products are designed for special risks. It also offers products in the excess and surplus markets, which provides an alternative for customers with risks or loss exposures that generally cannot be written in the standard admitted market. RLI distributes property and casualty insurance through its wholly-owned branch offices that market to wholesale and retail producers. The company's insurance operation segments include Casualty, Property, and Surety, and it derives a majority of its revenue from the Casualty segment.